Cerebellar Disorders and Movement Disorders Flashcards
What is cerebellar responsible for?
Cerebellum modulates Coordination and Learned Movement patterns rather than speed
Cerebellum receives afferents from Proprioceptive receptors (Inferior Cerebellar
Peduncles), Vestibular Nuclei, Basal Ganglia, Corticospinal System and Olivary Nuclei; Its
Effects leave (Mostly via Superior Cerebellar
Peduncles) to Red Nuclei, Vestibular Nuclei,
Basal Ganglia and Corticospinal System
What does the lateral cerebellar lobe do
Lateral Cerebellar Lobe (Cerebrocerebellum)
coordinates movement of Ipsilateral Limbs;
What does the vermis do?
Vermis (Spinocerebellum) concerned with
Maintenance of Axial Posture and Balance;
What does the flocculonodular lobe do?
Flocculonodular Lobe (Vestibulocerebellum) regulates Balance and Eye Movements
What causes cerebellar lesions?
Cerebellar Lesions can be caused by Obstructive Hydrocephalus; Severe Pressure Headaches, Vomiting and Papilloedema; Alternatively, Coning of Cerebellar Tonsils leads to Respiratory Arrest due to compression of the Brainstem
Lateral Cerebellar Hemisphere Lesions
• Disruption of Ipsilateral Normal Sequence of Movements (Dyssynergia); Rebound upward
overshoot; Gait becomes Broad and Ataxic faltering towards side of lesion
• Movement is imprecise in Direction, Force and Distance (Dysmetria); Dysdiadochokinesis
occurs; Intention Tremor and Past-Pointing; Speed of fine movements is preserved
• Nystagmus – Coarse Horizontal Nystagmus; Fast component moves towards side of lesion
• Dysarthria – Halting, Jerking, “Scanning” speech
• Titubation (Rhythmic head movements); Hypotonia and Hyporeflexia
Midline Cerebellar Lesions
- Difficulty standing and sitting unsupported (Truncal Ataxia) with a Rolling, Broad, Ataxic Gait
- Lesions of the Flocculonodular Node can cause Vertigo and Vomiting with Gait Ataxia
Physiological tremors
Physiologically normal 8-12Hz; Increased with Anxiety, Caffeine, Hyperthyroidism and Drugs; Occurs in Mercury poisoning
Coarse Postural Tremor
seen in Benign Essential Tremor (5-8Hz) and in ETOH XS
Intention Tremor
Exacerbated by Action; Associated with Past-pointing and Dysdiadochokinesis; Occurs in Cerebellar Lobe disease and Lesions of Cerebellar Peduncles;
Titubation and Nystagmus might be present
Rest Tremor
Seen typically in Parkinson’s Disease; Worse at rest; 4-7 Hz (Pill-rolling Tremor)
Coarse Tremors
can be seen in Red Nuclei lesions and rarely Frontal Lesions
Who gets idiopathic parkinsons disease?
Prevalence 150 in 100,000; Prevalence increases sharply with Age (1 in 200 of 80+yrs); 1.5× more common in Men; Small increased risk in Rural living and Well Water consumption; Pesticide induced (i.e. MPTP related) causes severe Parkinsonism; Non-smokers have a higher
risk of developing Parkinson’s Disease
Genetic Aetiology of IPD
• Significant genetic component; Gene Loci PARK 1-11; Rare but together account for large proportion of Early Onset and Familial Parkinson’s Disease
Pathophysiology of Parkinson’s Disease
Presence of Neuronal Inclusions (Lewy Bodies) and Loss of Dopaminergic Neurones in Substantia Nigra Pars Compacta
o Lewy Bodies contain tangles of α-Synuclein and Ubiquiti; Becomes more widespread as PD progresses, spreading to Lower Brainstem, Midbrain and Cortex
o Degeneration of other Basal Ganglia Nuclei; Degree of Nigrostriatal Dopaminergic Cell Loss correlates with severity of Akinesia
o Average of 70% lost by time of first presentation
Presentation of Parkinson’s Disease: Motor Symptoms
• Tremor – Starts in Fingers and Hands; Unilateral initially, spreading to leg on same side then opposite Arm; Present at rest and reduces when hand is in motion; Pill-rolling tremor pattern;
• Rigidity – Lead Pipe Rigidity; Not dependent on speed of movement (C/f Clasp Knife); Stiffness
+ Tremor = Cogwheel Rigidity
• Bradykinesia distinguished from Slowness of movements is progressive Fatiguing and
Decrement in Amplitude of repetitive movements; Difficulty initiating movement (usually Upper Limb); Rapid Dexterous movements impaired, Impassive Face (Serpentine Stare)
• Postural Instability – Stooped posture; Gait becomes shuffling with Small Stride, Slow Turns, Freezing and Reduced Arm Swing; May lead to falls although occurs late
• Micrographia (Writing becomes progressively smaller); Speech becomes Quiet, Indistinct and
Flat; Drooling and Dysphagia might feature; Leads to Aspiration Pneumonia
Presentation of Parkinson’s Disease: Non Motor
• Anosmia (90% of patients) – Dopamine transmission required for Olfaction
• Depression/Anxiety (50%), Aches/Pains, REM Sleep Behaviour Disorder, Autonomic Features
(Urinary Urgency, Hypotension), Constipation, Restless Leg Syndrome
• Cognitive – Common in late stage PD (80%), develop into Dementia; Depression is common due to involvement of Serotonergic and Adrenergic Systems; Anxiety is also comorbid
Progression of Parkinson’s
- PD progressively deteriorates; Most patients respond well to treatment but might become treatment unresponsive when Cognitive Impairment, Dysphagia and Postural Instability/Falls start to develop by mid-70s
- Death commonly resulting from Bronchopneumonia (Infective, Aspiration) and Immobility
Diagnosis of Parkinson’s Disease
• Clinical Diagnosis; rule out other Parkinsonian Syndromes
• MRI Head would be normal; Dopamine Transporter (DaT)
imaging to access Nigrostriatal Cell Loss; Cannot distinguish between PD and other Akinetic-Rigid
Syndromes but can rule out Drug Induced Parkinsonism
Treatment of Parkinson’s Disease
Dopamine Replacement is not always needed in Early-stage PD; Only started in disability;
Treatment of Non-Motor Symptoms E.g. Depression, Constipation, Pain and Sleep disorders
• Levodopa – Most effective form of treatment; Combined with DOPA Decarboxylase Inhibitor (e.g. Benserazide in Co-Beneldopa or Carbidopa in Co-Careldopa) to reduce Peripheral side
effects (Nausea, Hypotension)
Pharmacology of Parkinson’s treatment
• Dopamine Agonists – Used in combination with Levodopa or Initial Monotherapy in patients
65-70; Fewer motor complications but less effective and less tolerated then Levodopa
o Non-Ergot derived e.g. Pramipexole, Ropinirole used in preference to Ergot-derived, which are associated with fibrotic reactions (e.g. Valvular Fibrosis)
• Selegiline and Rasagiline (MAOB Inhibitors), Amantadine (? MOA), Anticholinergics (Rarely
used; Causes confusion in older patients), Apomorphine (Potent short acting Dopamine Agonist used as a rescue or maintenance by infusion pump for Advanced PD)
How does medical therapy change as PD develops
• Medical therapy becomes more difficult as disease progresses; Approximately 10% of patients per year develop complications from therapy (Wearing off, Dyskinesia/Choreiform
movements, On/Off Phenomenon);